Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy. - Wikidata - wikimedia - TriplyDB

Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy.

Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy.

http://www.wikidata.org/entity/Q37640298

about

Menopause and adipose tissue: miR-19a-3p is sensitive to hormonal replacement.Identification of novel genes in aging osteoblasts using next-generation sequencing and bioinformatics.miRNA as a New Regulatory Mechanism of Estrogen Vascular Action.

P2860

Q49443078-E7015EE0-48AD-440E-8637-5B96B0F58DEF Q49572000-6771D05B-7FE8-40D7-8952-71EE8C727169 Q50132060-6CC3221E-01C6-4DB6-9FFE-ADD43EA522CD

P2860

Aging and serum exomiR content in women-effects of estrogenic hormone replacement therapy.

http://www.wikidata.org/entity/Q37640298

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Aging and serum exomiR content ...... c hormone replacement therapy.

@en

Aging and serum exomiR content ...... c hormone replacement therapy.

@nl

type

label

Aging and serum exomiR content ...... c hormone replacement therapy.

@en

Aging and serum exomiR content ...... c hormone replacement therapy.

@nl

prefLabel

Aging and serum exomiR content ...... c hormone replacement therapy.

@en

Aging and serum exomiR content ...... c hormone replacement therapy.

@nl

P1433

Q37640298-D53AF3C1-22FD-483E-9428-9D2B8B7D52A3

P1476

Q37640298-0027AABA-265A-48F4-8EE4-A46EC53F3136

P2093

Q37640298-1CA38B2A-5090-49CA-986A-A2F97595DACC

Q37640298-6B459511-CD33-46E4-8E9C-A0C3853615B4

Q37640298-6C7998C6-9BE8-4E6D-B4E7-D149F35BB77B

Q37640298-D62DA346-DB27-4B8E-AA28-422B7D61BFDA

Q37640298-E2339BEF-CFDD-46FD-9052-0FD13093C2C3

Q37640298-E8E83D47-9AD5-482E-BA37-6C7CC9EA6808

P2860

Q37640298-00B005FC-6D6B-4A58-BADE-8AD19ABAB2C3

Q37640298-0423FCC9-CB8E-43D4-BCC3-645BAEEE0006

Q37640298-0450BF0F-F00A-420F-A7E1-618DA383F26B

Q37640298-049F87B5-CB19-47D1-B2EE-AA0F7A10B102

Q37640298-073146C4-0695-4090-86C5-F559F5DF71A1

Q37640298-096C9D2B-9122-4F95-BE1D-178949CDF5E6

Q37640298-0FE1AC08-91B7-4D96-A02B-6B2B113D11D7

Q37640298-1594E494-5919-42DF-8001-752E6674B427

Q37640298-17C1099C-700D-4EBF-ADEF-4689E5E45701

Q37640298-194F317E-EF91-46F1-9452-083EB0B87751

P2888

Q37640298-706CF037-7AEF-4F25-9678-0A3E3D5344E3

P304

Q37640298-DAD07874-357F-4E8C-87BB-DEEF0513A4A3

P31

Q37640298-9DBF3C3C-2D76-4090-9359-45465C47F705

P356

Q37640298-81F56B68-9619-46D5-B3A9-AE9376986C46

P407

Q37640298-867B2039-100D-4C37-9F3E-FBC433618E64

P478

Q37640298-C6C7AEC6-9F30-4F50-BEBF-41894F8906BE

P50

Q37640298-1E607691-F681-4D59-BF76-92240C08A2FF

Q37640298-31C60C78-E63F-4588-A466-227D3C6517FD

Q37640298-72E1BA03-1DEB-4076-B322-EE6B6C9E26F8

Q37640298-9285EAA9-CD38-442A-AA55-FD335D7179F1

Q37640298-E3AA9AC5-6344-4751-9AE1-F7BC675CBCA3

P577

Q37640298-68A98237-8F37-4141-A7AA-8D996E67DB12

P6179

Q37640298-30560803-0403-4DEF-9F63-A9C625CFA042

P698

Q37640298-7C246DEB-E4D2-489F-A941-6BB53AFAD2F2

P932

Q37640298-DAC09474-8F9E-42E0-AF2B-B4A7C0455479

P356

P1433

Scientific Reports

P1476

Aging and serum exomiR content ...... c hormone replacement therapy.

@en

P2093

Ilkka Miinalainen

http://www.w3.org/2001/XMLSchema#string

Juha Pursiheimo

http://www.w3.org/2001/XMLSchema#string

Markku Alen

http://www.w3.org/2001/XMLSchema#string

Reeta Kangas

http://www.w3.org/2001/XMLSchema#string

Vidal Fey

http://www.w3.org/2001/XMLSchema#string

Vuokko Kovanen

http://www.w3.org/2001/XMLSchema#string

P2860

Characterization of extracellular circulating microRNA

Insulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic Disorders

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules

MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins

Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection

CAP-miRSeq: a comprehensive analysis pipeline for microRNA sequencing data.

Genetic and environmental factors in complex diseases: the older Finnish Twin Cohort.

Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR

P2888

P304

42702

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP42702

http://www.w3.org/2001/XMLSchema#string

P407

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Sarianna Sipilä

Timo Törmäkangas

Anna-Marja Säämänen

P577

2017-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083820317

http://www.w3.org/2001/XMLSchema#string

P698

28195143

http://www.w3.org/2001/XMLSchema#string

P932

5307383

http://www.w3.org/2001/XMLSchema#string